Acetylsalicylic acid Completed Phase 3 Trials for Stroke, Ischemic Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01675115Efficacy of BNG-1 to Treat Acute Ischemic Stroke